Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications.
We provide:
- Classical and proprietary diet-induced in vivo models
- Innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, …)
- In vivo preclinical imaging services
Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making.
Company Details
- Employees
- 25
- Founded
- -
- Address
- Prologue Biotech, 516 Rue Pierre Et Marie Curie,france
- Industry
- Research
- Website
- physiogenex.com
- Keywords
- Preclinical services, CRO, pharmacology services, animal models, Metabolic syndrome, Diabesity, Dyslipidemia, Non alcoholic steatohepatitis, NASH, Liver diseases, Atherosclerosis, Type 2 diabetes, Obesity, In vivo efficacy models, ex vivo assays.
- HQ
- Labège
Physiogenex Questions
Physiogenex's website is physiogenex.com
Physiogenex's LinkedIn profile is https://fr.linkedin.com/company/physiogenex
Physiogenex has
25 employees.
View email and phone details for 25
employees at Physiogenex.
Physiogenex's industry is
Research
Physiogenex's top competitors are
Flash Biosolutions,
Enterosys - Gut Is The Link,
Jc Discovery,
Imavita,
Cardiomedex,
Antabio,
Cell-Easy,
Olon France,
Ambiotis,
Urosphere.
Physiogenex's categories are Research
Physiogenex's founding year is 2003
